drugset / Trial / NCT00094432
A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
Phase 3
Completed
650 enrolled
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka America Pharmaceutical · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate several doses of aripiprazole in patients with bipolar depression.
Timeline
- Start
- 2004-06
- Primary completion
- 2006-11
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aripiprazole | Other / unclassified | 10 mg | Oral |